This disruption in hippocampal interneurons appears to be driven by abnormal responses to stress occurring in the peripubertal time period. Thus, in MAM rats there is hyperactivity peripubertally both in the amygdala and in its target area, the ventral hippocampus. Such hyperactivity is proposed to lead to the interneuron loss, thereby producing abnormal hippocampal function in the adult. We found that administration of an antianxiety drug during the peripubertal period at doses that relieve the hyperanxious state prevents the development of dopamine system hyper-responsivity in the adult rat. Therefore, examining the circuitry underlying dopamine system disruption in this developmental model of psychosis can contribute both to a better understanding of the pathophysiology of major psychiatric disorders, as well as glean insights into novel avenues of treatment and potentially in preventing the emergence of schizophrenia in susceptible individuals. 1 The serotonergic system is implicated in the etiology and treatment of mood disorders.
. However, this process is severely compromised by the simultaneous activation of somatodendritic 5-HT 1A -autoreceptors in the midbrain raphe nuclei after serotonin transporter (SERT) blockade or MAO inhibition 4, 5 . 5-HT 1A -autoreceptor activation reduces serotonergic activity and forebrain 5-HT release, an effect contrary to that required for the therapeutic response. [3] [4] [5] [6] Hence, the limited clinical efficacy of 5-HT-enhancing drugs and their delayed action are partly due to this negative feedback mechanism. Upon chronic treatment, 5-HT 1A -autoreceptors desensitize, leading to the recovery of serotonergic activity and 5-HT release.
3,6 Individuals with elevated density or activity of 5-HT 1A -autoreceptors are more susceptible to mood disorders and respond poorly to antidepressants. [7] [8] [9] 5-HT 1A R antagonists might thus be useful to improve antidepressant therapy by preventing the 5-HT 1A -autoreceptor-mediated negative feedback. However, the activation of postsynaptic 5-HT 1A R is a necessary step for antidepressant effects 6 which limits the usefulness of this strategy. Thus, unlike the non-selective 5-HT 1A R/ß-adrenoceptor antagonist pindolol [10] [11] [12] (with a preferential action at 5-HT 1A -autoreceptors), the selective 5-HT 1A R antagonist DU-125530 does not enhance clinical fluoxetine effects despite augmenting the presynaptic effects of SSRI. 13 Overall, these observations have led to the development of antidepressant drugs combining SERT inhibition with partial agonist effects on 5-HT 1A -R, such as vilazodone 14 or vortioxetine (the latter compound is also antagonist at other 5-HT receptors 15 ).
In recent years we have used a new antidepressant strategy, based on the use of small interfering RNA (siRNA) targeted to serotonin neurons, to selectively reduce the expression and function of presynaptic (but not postsynaptic) 5-HT 1A R. Local siRNA application in the raphe nuclei of mice reduced the expression and function of 5-HT 1A autoreceptors locally, without affecting postsynaptic 5-HT 1A R. This resulted in an antidepressant-like effect in the forced-swim and tail suspension tests, associated to an enhanced forebrain 5-HT release. 16 We also developed a conjugated 5-HT 1A R siRNA (C-1A-siRNA) directed to serotonin neurons, by covalently binding 5-HT 1A R siRNA molecules to the SSRI sertraline. The intracerebroventricular or intranasal application of the C-1A-siRNA produced a selective reduction of 5-HT 1A autoreceptor expression/function without affecting postsynaptic 5-HT 1A R. This effect was associated to an antidepressant-like effect. Likewise, SSRI administration to C-1A-siRNA-treated mice produced a greater elevation of extracellular 5-HT than in control mice.
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Overall, existing evidence indicates that pre-and postsynaptic 5-HT 1A -R play a major role in antidepressant action, either by limiting (presynaptic 5-HT 1A autorecepors) or facilitating their effects (postsynaptic 5-HYT 1A -R).
Abstract Serotonin (5-HT) is a major neuromodulator implicated in a broad assortment of behavioral and physiological functions, including aggression, appetite, aversion, behavioral inhibition and impulsivity. The 5-HT system is one of the most important targets for the treatment of depression. It has been difficult, however, to explain the diverse effects of serotonin on adaptive behavior within a unified framework. Based on the review of experimental data and theoretical models, we previously proposed a model in which the function of serotonin is to modulate the value of waiting for a future reward. In this hypothesis, a higher level of 5-HT means a higher setting of the discount factor, which promotes waiting for longer delays. A low level of serotonin is often associated with impulsive behaviors (Doya, 2002) . Here, we show a part of the results of a series of research carried out based on the hypothesis.
Human functional magnetic resonance imaging (fMRI) studies show differential involvement of brain areas in the prediction of immediate and delayed rewards, with the dorsal striatum and prefrontal cortex showing consistent activity for delayed rewards (Tanaka et al., 2004) . To elucidate the role of serotonin in the evaluation of delayed rewards, we performed an fMRI experiment in which subjects chose either small-immediate or large-delayed rewards under dietary regulation of tryptophan, a precursor of serotonin. The study showed that the dorsal striatal activity correlated with long-term reward prediction was enhanced with the activation of the serotonergic system (Tanaka et al., 2007) . From the behavioral data, we found an increase of proportion in small reward choices, together with an increase in the rate of discounting of delayed rewards in the low-serotonin condition compared with the control and highserotonin conditions (Schweighofer et al., 2008) . Recently, we found the attenuated activation in the dorsal striatum during waiting for delayed rewards in depressed patients (Okada et al., in preparation) .
To examine any causal relationship between serotonergic activity and waiting behavior for delayed reward, we applied a 5-HT 1A receptor agonist locally in the dorsal raphe nucleus (DRN) in rats; this treatment is known to suppress 5-HT neural activity through autoreceptors. Rats performed a sequential food-water navigation task in which they alternately visited food and water sites to acquire rewards after waiting periods. The rats performed the task under two reward conditions: a short delayed reward condition and a long delayed reward condition. We found that the suppression of 5-HT neural activity in the DRN by a 5-HT 1A receptor agonist increased premature exit from reward sites before the delivery of delayed rewards, which indicated impaired patience for delayed rewards (Miyazaki et al., 2012) .
From both human and animal studies, these results strongly supported our hypothesis that 5-HT promotes waiting for longer delays, and might explain not only impulsive behavior, but also certain aspects of depressive behavior.
